Trial Number
528-24
Condition
Stroke
Participant Age Range
18 years to 90 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke with Late Presentations”
This study is designed to evaluate the Efficacy and safety of JX10 in Acute Ischemic Stroke with Late Presentations